Report in Good Clinical Practice Journal (GCPj) Finds That Novartis
Leads the Pack for Ongoing Trials in Autoimmune, Cardiovascular,
and Metabolic Diseases
NEW YORK, June 30, 2008 /PRNewswire/ -- In a new Expert Analysis
article published in the...
June 30, 2008 | Filed Under News
Comments